Eton Pharmaceuticals, Inc. (ETON)
63.34
-1.09
(-1.69%)
USD |
NASDAQ |
Aug 25, 13:43
Eton Pharmaceuticals Total Liabilities (Quarterly) : 69.22M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 69.22M |
| March 31, 2026 | 67.10M |
| December 31, 2025 | 65.96M |
| September 30, 2025 | 81.38M |
| June 30, 2025 | 77.72M |
| March 31, 2025 | 59.58M |
| December 31, 2024 | 51.70M |
| September 30, 2024 | 19.86M |
| June 30, 2024 | 18.36M |
| March 31, 2024 | 15.30M |
| December 31, 2023 | 16.26M |
| September 30, 2023 | 14.63M |
| June 30, 2023 | 14.21M |
| March 31, 2023 | 12.69M |
| December 31, 2022 | 11.95M |
| September 30, 2022 | 10.34M |
| June 30, 2022 | 9.804M |
| March 31, 2022 | 9.813M |
| Date | Value |
|---|---|
| December 31, 2021 | 9.835M |
| September 30, 2021 | 10.95M |
| June 30, 2021 | 9.17M |
| March 31, 2021 | 9.631M |
| December 31, 2020 | 10.66M |
| September 30, 2020 | 10.01M |
| June 30, 2020 | 7.528M |
| March 31, 2020 | 6.621M |
| December 31, 2019 | 6.522M |
| September 30, 2019 | 1.159M |
| June 30, 2019 | 1.545M |
| March 31, 2019 | 3.775M |
| December 31, 2018 | 2.024M |
| September 30, 2018 | 2.774M |
| June 30, 2018 | 2.15M |
| March 31, 2018 | 1.55M |
| December 31, 2017 | 1.313M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nektar Therapeutics | 192.01M |
| Pfizer Inc. | 115.64B |
| Elite Pharmaceuticals, Inc. | 34.84M |
| Daré Bioscience, Inc. | 22.93M |
| Liquidia Corp. | 326.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.81M |
| Shareholders Equity (Quarterly) | 46.58M |
| Debt to Equity Ratio | 0.6273 |
| Current Ratio | 1.520 |
| Net Debt Paydown Yield | 0.02% |